FUT3
Basic information
Region (hg38): 19:5842888-5851471
Previous symbols: [ "LE" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Blood group, Lewis system | AD | Hematologic | Variants may be associated with a blood group may be important in specific situations (eg, related to transfusion) | Hematologic | 2922027; 7961897; 8943285; 9703429; 11668626; 15383031 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FUT3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 32 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 6 | 4 |
Variants in FUT3
This is a list of pathogenic ClinVar variants found in the FUT3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-5843785-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
19-5843811-T-C | Likely benign (Jul 06, 2018) | |||
19-5843851-G-A | not specified | Likely benign (Mar 15, 2024) | ||
19-5843865-C-T | FUT3-related disorder | Benign (Mar 30, 2023) | ||
19-5843896-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
19-5843929-C-T | not specified | Likely benign (Jul 25, 2023) | ||
19-5843930-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
19-5843930-G-C | not specified | Uncertain significance (Feb 28, 2023) | ||
19-5843947-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
19-5844014-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
19-5844027-G-A | FUT3-related disorder | Likely benign (Dec 06, 2019) | ||
19-5844068-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
19-5844082-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
19-5844099-G-A | FUT3-related disorder | Likely benign (Mar 30, 2021) | ||
19-5844108-G-A | Benign (Jun 12, 2018) | |||
19-5844130-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
19-5844161-T-C | not specified | Uncertain significance (Oct 03, 2022) | ||
19-5844170-G-A | not specified | Uncertain significance (Jul 27, 2022) | ||
19-5844218-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
19-5844224-T-A | not specified | Uncertain significance (Dec 12, 2023) | ||
19-5844228-T-C | FUT3-related disorder | Likely benign (Jul 23, 2018) | ||
19-5844244-T-C | not specified | Uncertain significance (May 20, 2024) | ||
19-5844270-G-A | FUT3-related disorder | Likely benign (Oct 26, 2022) | ||
19-5844310-C-T | not specified | Uncertain significance (May 23, 2024) | ||
19-5844322-T-C | not specified | Uncertain significance (Jul 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FUT3 | protein_coding | protein_coding | ENST00000303225 | 1 | 8587 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000630 | 0.163 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.259 | 238 | 227 | 1.05 | 0.0000163 | 2317 |
Missense in Polyphen | 63 | 72.73 | 0.86622 | 856 | ||
Synonymous | -1.99 | 130 | 104 | 1.25 | 0.00000804 | 761 |
Loss of Function | -1.39 | 5 | 2.59 | 1.93 | 1.13e-7 | 25 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000527 | 0.0000527 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May catalyze alpha-1,3 and alpha-1,4 glycosidic linkages involved in the expression of Vim-2, Lewis A, Lewis B, sialyl Lewis X and Lewis X/SSEA-1 antigens. May be involved in blood group Lewis determination; Lewis-positive (Le(+)) individuals have an active enzyme while Lewis-negative (Le(-)) individuals have an inactive enzyme. Also acts on the corresponding 1,4-galactosyl derivative, forming 1,3-L-fucosyl links.;
- Pathway
- Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human);Glycosphingolipid biosynthesis - lactoseries;Post-translational protein modification;Reactions specific to the complex N-glycan synthesis pathway;N-glycan antennae elongation in the medial/trans-Golgi;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.188
Intolerance Scores
- loftool
- 0.628
- rvis_EVS
- 2.6
- rvis_percentile_EVS
- 98.77
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- N
- hipred_score
- 0.290
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.234
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- protein glycosylation;ceramide metabolic process;oligosaccharide biosynthetic process;cell-cell recognition;fucosylation;macromolecule glycosylation
- Cellular component
- Golgi membrane;membrane;integral component of membrane;Golgi cisterna membrane;extracellular exosome
- Molecular function
- fucosyltransferase activity;3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity;alpha-(1->3)-fucosyltransferase activity